Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer

被引：0
|
作者：
Jichao He
Ronan P. McLaughlin
Vera van der Noord
John A. Foekens
John W. M. Martens
Gerard van Westen
Yinghui Zhang
Bob van de Water
机构：
[1] Leiden University,Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research
[2] Erasmus Medical Centre,Department of Medical Oncology and Cancer Genomic Netherlands, Erasmus MC Cancer Institute
来源：
Breast Cancer Research and Treatment | 2019年 / 178卷
关键词：
Multi-kinase inhibitor; mTOR-targeted therapy; Drug resistance; Triple-negative breast cancer (TNBC); Polypharmacology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：263 / 274
页数：11
相关论文
共 50 条
  • [21] Effect of mTOR inhibition on sensitivity of triple-negative breast cancer cells to epidermal growth factor inhibition
    Liu, T.
    Yacoub, R.
    Graham, T.
    Yang, L.
    Tighiouart, M.
    O'Regan, R. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [22] Targeting the mTOR pathway for the prevention of triple-negative breast cancer
    Brown, Powel H.
    Mazumdar, Abhijit
    Tahaney, William
    Hill, Jamal
    Zhang, Yun
    Ramachandran, Sumankalai
    Kawedia, Jitesh
    Qian, Jing
    Contreras, Alejandra
    Savage, Michelle
    Vornik, Lana
    CANCER PREVENTION RESEARCH, 2023, 16 (01)
  • [23] Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer
    Duncan, James S.
    Whittle, Martin C.
    Nakamura, Kazuhiro
    Abell, Amy N.
    Midland, Alicia A.
    Zawistowski, Jon S.
    Johnson, Nancy L.
    Granger, Deborah A.
    Jordan, Nicole Vincent
    Darr, David B.
    Usary, Jerry
    Kuan, Pei-Fen
    Smalley, David M.
    Major, Ben
    He, Xiaping
    Hoadley, Katherine A.
    Zhou, Bing
    Sharpless, Norman E.
    Perou, Charles M.
    Kim, William Y.
    Gomez, Shawn M.
    Chen, Xin
    Jin, Jian
    Frye, Stephen V.
    Earp, H. Shelton
    Graves, Lee M.
    Johnson, Gary L.
    CELL, 2012, 149 (02) : 307 - 321
  • [24] Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer
    Granados-Principal, Sergio
    Liu, Yi
    Guevara, Maria L.
    Blanco, Elvin
    Choi, Dong Soon
    Qian, Wei
    Patel, Tejal
    Rodriguez, Angel A.
    Cusimano, Joseph
    Weiss, Heidi L.
    Zhao, Hong
    Landis, Melissa D.
    Dave, Bhuvanesh
    Gross, Steven S.
    Chang, Jenny C.
    BREAST CANCER RESEARCH, 2015, 17
  • [25] Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer
    Sergio Granados-Principal
    Yi Liu
    Maria L Guevara
    Elvin Blanco
    Dong Soon Choi
    Wei Qian
    Tejal Patel
    Angel A Rodriguez
    Joseph Cusimano
    Heidi L Weiss
    Hong Zhao
    Melissa D Landis
    Bhuvanesh Dave
    Steven S Gross
    Jenny C Chang
    Breast Cancer Research, 17
  • [26] Multi-Targeted and On-Demand Non-Coding RNA Regulation Nanoplatform against Metastasis and Recurrence of Triple-Negative Breast Cancer
    Song, Linjiang
    Yang, Jin
    Qin, Zeyi
    Ou, Chunqing
    Luo, Rui
    Yang, Wen
    Wang, Li
    Wang, Ning
    Ma, Shuang
    Wu, Qinjie
    Gong, Changyang
    SMALL, 2023, 19 (23)
  • [27] TKI258, a novel, multi-targeted tyrosine kinase inhibitor for the treatment of breast cancer
    Liu, Hongyu
    Dieing, Annette
    Lehenbauer-Dehm, Sylvia
    Kuehnhardt, Dagmar
    Regierer, Anne
    Schulz, Carsten
    Storek, Benjamin
    Schwarck, Sandra
    Possinger, Kurt
    Eucker, Jan
    CANCER RESEARCH, 2009, 69
  • [28] Lipogenesis inhibition in triple-negative breast cancer (TNBC)
    Giro-Perafita, Ariadna
    Palomeras, Sonia
    Polonio, Emma
    Ciurana, Joaquim
    Vinas, Gemma
    Puig, Teresa
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2017, 40 : S58 - S58
  • [29] mTOR in breast cancer: Differential expression in triple-negative and non-triple-negative tumors
    Walsh, S.
    Flanagan, L.
    Quinn, C.
    Evoy, D.
    McDermott, E. W.
    Pierce, A.
    Duffy, M. J.
    BREAST, 2012, 21 (02): : 178 - 182
  • [30] Screening of a kinase inhibitor library identified novel targetable kinase pathways in triple-negative breast cancer
    Rinderle, Caroline H.
    Baker, Christopher V.
    Lagarde, Courtney B.
    Nguyen, Khoa
    Al-Ghadban, Sara
    Matossian, Margarite D.
    Hoang, Van T.
    Martin, Elizabeth C.
    Collins-Burow, Bridgette M.
    Ali, Simak
    Drewry, David H.
    Burow, Matthew E.
    Bunnell, Bruce A.
    ANTI-CANCER DRUGS, 2025, 36 (01) : 39 - 48
12345